25 XP   0   0   10

Coloplast A/S
Buy, Hold or Sell?

Let's analyse Coloplast together

PenkeI guess you are interested in Coloplast A/S. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Coloplast A/S. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Coloplast A/S

I send you an email if I find something interesting about Coloplast A/S.

Quick analysis of Coloplast (30 sec.)










What can you expect buying and holding a share of Coloplast? (30 sec.)

How much money do you get?

How much money do you get?
€3.12
When do you have the money?
1 year
How often do you get paid?
55.0%

What is your share worth?

Current worth
€9.65
Expected worth in 1 year
€15.22
How sure are you?
97.5%

+ What do you gain per year?

Total Gains per Share
€8.43
Return On Investment
7.5%

For what price can you sell your share?

Current Price per Share
€112.70
Expected price per share
€103.50 - €130.95
How sure are you?
50%

1. Valuation of Coloplast (5 min.)




Live pricePrice per Share (EOD)

€112.70

Intrinsic Value Per Share

€-81.77 - €-15.85

Total Value Per Share

€-72.12 - €-6.20

2. Growth of Coloplast (5 min.)




Is Coloplast growing?

Current yearPrevious yearGrowGrow %
How rich?$2.3b$1b$996m49.7%

How much money is Coloplast making?

Current yearPrevious yearGrowGrow %
Making money$180.5m$174.5m$5.9m3.3%
Net Profit Margin19.5%19.7%--

How much money comes from the company's main activities?

3. Financial Health of Coloplast (5 min.)




4. Comparing to competitors in the Medical Instruments & Supplies industry (5 min.)




  Industry Rankings (Medical Instruments & Supplies)  


Richest
#26 / 168

Most Revenue
#20 / 168

Most Profit
#13 / 168

What can you expect buying and holding a share of Coloplast? (5 min.)

Welcome investor! Coloplast's management wants to use your money to grow the business. In return you get a share of Coloplast.

What can you expect buying and holding a share of Coloplast?

First you should know what it really means to hold a share of Coloplast. And how you can make/lose money.

Speculation

The Price per Share of Coloplast is €112.70. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Coloplast.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Coloplast, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €9.65. Based on the TTM, the Book Value Change Per Share is €1.39 per quarter. Based on the YOY, the Book Value Change Per Share is €-0.12 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.72 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Coloplast.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.810.7%0.820.7%0.820.7%0.770.7%0.650.6%
Usd Book Value Change Per Share0.420.4%1.511.3%-0.13-0.1%0.310.3%0.160.1%
Usd Dividend Per Share0.000.0%0.780.7%1.451.3%0.840.7%0.670.6%
Usd Total Gains Per Share0.420.4%2.292.0%1.321.2%1.151.0%0.830.7%
Usd Price Per Share134.63-120.16-121.40-132.84-103.70-
Price to Earnings Ratio41.53-36.61-37.09-43.43-36.40-
Price-to-Total Gains Ratio322.07-150.09-175.92-184.89-160.60-
Price to Book Ratio12.84-15.45-25.99-26.93-23.92-
Price-to-Total Gains Ratio322.07-150.09-175.92-184.89-160.60-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share122.41474
Number of shares8
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.780.84
Usd Book Value Change Per Share1.510.31
Usd Total Gains Per Share2.291.15
Gains per Quarter (8 shares)18.329.22
Gains per Year (8 shares)73.2936.89
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1254863271027
25097136542064
3751452098130101
410019328210740138
512524235513450175
615029042816160212
717533850118870249
820038757421580286
922543564724290323
10250483720268101360

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%39.01.00.097.5%60.02.00.096.8%
Book Value Change Per Share2.02.00.050.0%6.06.00.050.0%10.010.00.050.0%19.021.00.047.5%32.027.03.051.6%
Dividend per Share2.00.02.050.0%8.00.04.066.7%12.00.08.060.0%22.00.018.055.0%29.00.033.046.8%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%39.01.00.097.5%58.02.02.093.5%

Fundamentals of Coloplast

About Coloplast A/S

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. The company was founded in 1954 and is headquartered in Humlebæk, Denmark.

Fundamental data was last updated by Penke on 2024-05-26 08:10:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of Coloplast A/S.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Coloplast earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Coloplast to the Medical Instruments & Supplies industry mean.
  • A Net Profit Margin of 19.0% means that €0.19 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Coloplast A/S:

  • The MRQ is 19.0%. The company is making a huge profit. +2
  • The TTM is 19.5%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ19.0%TTM19.5%-0.5%
TTM19.5%YOY19.7%-0.3%
TTM19.5%5Y21.4%-1.9%
5Y21.4%10Y20.8%+0.6%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ19.0%5.3%+13.7%
TTM19.5%5.9%+13.6%
YOY19.7%5.1%+14.6%
5Y21.4%7.0%+14.4%
10Y20.8%6.7%+14.1%
1.1.2. Return on Assets

Shows how efficient Coloplast is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Coloplast to the Medical Instruments & Supplies industry mean.
  • 2.6% Return on Assets means that Coloplast generated €0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Coloplast A/S:

  • The MRQ is 2.6%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.8%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.6%TTM2.8%-0.2%
TTM2.8%YOY3.4%-0.6%
TTM2.8%5Y5.6%-2.8%
5Y5.6%10Y6.2%-0.5%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ2.6%0.7%+1.9%
TTM2.8%0.9%+1.9%
YOY3.4%1.4%+2.0%
5Y5.6%1.5%+4.1%
10Y6.2%1.5%+4.7%
1.1.3. Return on Equity

Shows how efficient Coloplast is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Coloplast to the Medical Instruments & Supplies industry mean.
  • 7.7% Return on Equity means Coloplast generated €0.08 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Coloplast A/S:

  • The MRQ is 7.7%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 10.6%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ7.7%TTM10.6%-2.9%
TTM10.6%YOY17.5%-6.9%
TTM10.6%5Y15.5%-4.9%
5Y15.5%10Y15.0%+0.5%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ7.7%1.5%+6.2%
TTM10.6%1.8%+8.8%
YOY17.5%2.7%+14.8%
5Y15.5%3.0%+12.5%
10Y15.0%2.8%+12.2%

1.2. Operating Efficiency of Coloplast A/S.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Coloplast is operating .

  • Measures how much profit Coloplast makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Coloplast to the Medical Instruments & Supplies industry mean.
  • An Operating Margin of 27.7% means the company generated €0.28  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Coloplast A/S:

  • The MRQ is 27.7%. The company is operating very efficient. +2
  • The TTM is 27.3%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ27.7%TTM27.3%+0.4%
TTM27.3%YOY28.4%-1.1%
TTM27.3%5Y30.0%-2.7%
5Y30.0%10Y31.1%-1.1%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ27.7%7.4%+20.3%
TTM27.3%4.6%+22.7%
YOY28.4%9.3%+19.1%
5Y30.0%9.5%+20.5%
10Y31.1%9.0%+22.1%
1.2.2. Operating Ratio

Measures how efficient Coloplast is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • An Operation Ratio of 0.73 means that the operating costs are €0.73 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Coloplast A/S:

  • The MRQ is 0.728. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.725. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.728TTM0.725+0.003
TTM0.725YOY0.715+0.011
TTM0.7255Y0.696+0.029
5Y0.69610Y0.687+0.009
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7281.111-0.383
TTM0.7251.124-0.399
YOY0.7151.149-0.434
5Y0.6961.110-0.414
10Y0.6871.051-0.364

1.3. Liquidity of Coloplast A/S.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Coloplast is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A Current Ratio of 0.60 means the company has €0.60 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Coloplast A/S:

  • The MRQ is 0.600. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.681. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.600TTM0.681-0.081
TTM0.681YOY1.013-0.332
TTM0.6815Y0.936-0.255
5Y0.93610Y1.055-0.119
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6002.311-1.711
TTM0.6812.401-1.720
YOY1.0132.556-1.543
5Y0.9362.672-1.736
10Y1.0552.619-1.564
1.3.2. Quick Ratio

Measures if Coloplast is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Coloplast to the Medical Instruments & Supplies industry mean.
  • A Quick Ratio of 0.32 means the company can pay off €0.32 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Coloplast A/S:

  • The MRQ is 0.320. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.355. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.320TTM0.355-0.036
TTM0.355YOY0.526-0.170
TTM0.3555Y0.543-0.188
5Y0.54310Y0.464+0.079
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3201.064-0.744
TTM0.3551.064-0.709
YOY0.5261.231-0.705
5Y0.5431.369-0.826
10Y0.4641.553-1.089

1.4. Solvency of Coloplast A/S.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Coloplast assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Coloplast to Medical Instruments & Supplies industry mean.
  • A Debt to Asset Ratio of 0.66 means that Coloplast assets are financed with 66.3% credit (debt) and the remaining percentage (100% - 66.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Coloplast A/S:

  • The MRQ is 0.663. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.702. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.663TTM0.702-0.039
TTM0.702YOY0.803-0.101
TTM0.7025Y0.633+0.069
5Y0.63310Y0.582+0.052
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6630.348+0.315
TTM0.7020.356+0.346
YOY0.8030.343+0.460
5Y0.6330.361+0.272
10Y0.5820.365+0.217
1.4.2. Debt to Equity Ratio

Measures if Coloplast is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Coloplast to the Medical Instruments & Supplies industry mean.
  • A Debt to Equity ratio of 197.2% means that company has €1.97 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Coloplast A/S:

  • The MRQ is 1.972. The company is just able to pay all its debts with equity.
  • The TTM is 2.594. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ1.972TTM2.594-0.622
TTM2.594YOY4.151-1.558
TTM2.5945Y2.182+0.411
5Y2.18210Y1.688+0.494
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9720.521+1.451
TTM2.5940.546+2.048
YOY4.1510.500+3.651
5Y2.1820.611+1.571
10Y1.6880.642+1.046

2. Market Valuation of Coloplast A/S

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Coloplast generates.

  • Above 15 is considered overpriced but always compare Coloplast to the Medical Instruments & Supplies industry mean.
  • A PE ratio of 41.53 means the investor is paying €41.53 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Coloplast A/S:

  • The EOD is 37.764. Based on the earnings, the company is overpriced. -1
  • The MRQ is 41.534. Based on the earnings, the company is overpriced. -1
  • The TTM is 36.610. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD37.764MRQ41.534-3.770
MRQ41.534TTM36.610+4.924
TTM36.610YOY37.087-0.477
TTM36.6105Y43.433-6.823
5Y43.43310Y36.404+7.029
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD37.76417.121+20.643
MRQ41.53416.169+25.365
TTM36.61016.130+20.480
YOY37.08721.198+15.889
5Y43.43320.998+22.435
10Y36.40427.674+8.730
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Coloplast A/S:

  • The EOD is -16.683. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -18.349. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 22.383. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD-16.683MRQ-18.349+1.665
MRQ-18.349TTM22.383-40.731
TTM22.383YOY98.942-76.559
TTM22.3835Y-231.433+253.815
5Y-231.43310Y-71.924-159.509
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-16.683-1.121-15.562
MRQ-18.349-1.779-16.570
TTM22.3832.017+20.366
YOY98.9424.353+94.589
5Y-231.4337.535-238.968
10Y-71.9240.417-72.341
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Coloplast is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A PB ratio of 12.84 means the investor is paying €12.84 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Coloplast A/S:

  • The EOD is 11.674. Based on the equity, the company is expensive. -2
  • The MRQ is 12.840. Based on the equity, the company is expensive. -2
  • The TTM is 15.446. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD11.674MRQ12.840-1.165
MRQ12.840TTM15.446-2.606
TTM15.446YOY25.992-10.546
TTM15.4465Y26.934-11.488
5Y26.93410Y23.916+3.018
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD11.6742.758+8.916
MRQ12.8402.732+10.108
TTM15.4462.691+12.755
YOY25.9922.970+23.022
5Y26.9344.092+22.842
10Y23.9164.408+19.508
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Coloplast A/S compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.3851.391-72%-0.120+131%0.289+33%0.149+159%
Book Value Per Share--9.6548.329+16%4.367+121%5.059+91%4.194+130%
Current Ratio--0.6000.681-12%1.013-41%0.936-36%1.055-43%
Debt To Asset Ratio--0.6630.702-5%0.803-17%0.633+5%0.582+14%
Debt To Equity Ratio--1.9722.594-24%4.151-53%2.182-10%1.688+17%
Dividend Per Share---0.718-100%1.338-100%0.772-100%0.614-100%
Eps--0.7460.755-1%0.756-1%0.713+5%0.598+25%
Free Cash Flow Per Share---1.6890.171-1090%0.441-483%0.463-465%0.454-472%
Free Cash Flow To Equity Per Share---0.0171.223-101%0.060-128%0.597-103%0.310-105%
Gross Profit Margin---0.719-0.623-13%-0.564-22%-0.410-43%-0.284-60%
Intrinsic Value_10Y_max---15.851--------
Intrinsic Value_10Y_min---81.773--------
Intrinsic Value_1Y_max--1.325--------
Intrinsic Value_1Y_min---0.065--------
Intrinsic Value_3Y_max--1.761--------
Intrinsic Value_3Y_min---7.238--------
Intrinsic Value_5Y_max---0.480--------
Intrinsic Value_5Y_min---22.073--------
Market Cap23333408000.000-19%27851565000.00024352647197.700+14%23746742997.013+17%26195230040.830+6%20399428717.698+37%
Net Profit Margin--0.1900.195-2%0.197-4%0.214-11%0.208-9%
Operating Margin--0.2770.273+2%0.284-2%0.300-8%0.311-11%
Operating Ratio--0.7280.725+0%0.715+2%0.696+5%0.687+6%
Pb Ratio11.674-10%12.84015.446-17%25.992-51%26.934-52%23.916-46%
Pe Ratio37.764-10%41.53436.610+13%37.087+12%43.433-4%36.404+14%
Price Per Share112.700-10%123.950110.625+12%111.763+11%122.295+1%95.470+30%
Price To Free Cash Flow Ratio-16.683+9%-18.34922.383-182%98.942-119%-231.433+1161%-71.924+292%
Price To Total Gains Ratio292.841-10%322.073150.090+115%175.921+83%184.886+74%160.598+101%
Quick Ratio--0.3200.355-10%0.526-39%0.543-41%0.464-31%
Return On Assets--0.0260.028-8%0.034-24%0.056-54%0.062-58%
Return On Equity--0.0770.106-27%0.175-56%0.155-50%0.150-48%
Total Gains Per Share--0.3852.108-82%1.219-68%1.061-64%0.763-50%
Usd Book Value--2356163316.0002003975077.130+18%1007950667.945+134%1185244685.365+99%977495075.453+141%
Usd Book Value Change Per Share--0.4181.510-72%-0.130+131%0.314+33%0.161+159%
Usd Book Value Per Share--10.4869.047+16%4.743+121%5.495+91%4.556+130%
Usd Dividend Per Share---0.780-100%1.454-100%0.839-100%0.667-100%
Usd Eps--0.8100.821-1%0.822-1%0.775+5%0.649+25%
Usd Free Cash Flow---412183138.12038287653.885-1177%101918607.635-504%106747288.011-486%104849267.562-493%
Usd Free Cash Flow Per Share---1.8340.185-1090%0.480-483%0.502-465%0.493-472%
Usd Free Cash Flow To Equity Per Share---0.0181.329-101%0.065-128%0.649-103%0.337-105%
Usd Market Cap25344747769.600-19%30252369903.00026451845386.142+14%25793712243.355+17%28453258870.350+6%22157859473.163+37%
Usd Price Per Share122.415-10%134.634120.161+12%121.396+11%132.837+1%103.699+30%
Usd Profit--182093609.360180530105.925+1%174566976.545+4%166065881.124+10%138755475.775+31%
Usd Revenue--957882197.480928139271.670+3%884761141.485+8%783329765.153+22%666685136.793+44%
Usd Total Gains Per Share--0.4182.290-82%1.324-68%1.153-64%0.829-50%
 EOD+3 -5MRQTTM+14 -22YOY+15 -215Y+16 -2010Y+14 -22

3.2. Fundamental Score

Let's check the fundamental score of Coloplast A/S based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1537.764
Price to Book Ratio (EOD)Between0-111.674
Net Profit Margin (MRQ)Greater than00.190
Operating Margin (MRQ)Greater than00.277
Quick Ratio (MRQ)Greater than10.320
Current Ratio (MRQ)Greater than10.600
Debt to Asset Ratio (MRQ)Less than10.663
Debt to Equity Ratio (MRQ)Less than11.972
Return on Equity (MRQ)Greater than0.150.077
Return on Assets (MRQ)Greater than0.050.026
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Coloplast A/S based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.912
Ma 20Greater thanMa 50112.270
Ma 50Greater thanMa 100115.392
Ma 100Greater thanMa 200112.554
OpenGreater thanClose113.650
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in DKK. All numbers in thousands.

Summary
Total Assets48,140,000
Total Liabilities31,940,000
Total Stockholder Equity16,200,000
 As reported
Total Liabilities 31,940,000
Total Stockholder Equity+ 16,200,000
Total Assets = 48,140,000

Assets

Total Assets48,140,000
Total Current Assets10,391,000
Long-term Assets37,749,000
Total Current Assets
Cash And Cash Equivalents 889,000
Net Receivables 4,641,000
Inventory 3,562,000
Other Current Assets 1,299,000
Total Current Assets  (as reported)10,391,000
Total Current Assets  (calculated)10,391,000
+/-0
Long-term Assets
Property Plant Equipment 6,319,000
Intangible Assets 30,403,000
Long-term Assets Other 34,000
Long-term Assets  (as reported)37,749,000
Long-term Assets  (calculated)36,756,000
+/- 993,000

Liabilities & Shareholders' Equity

Total Current Liabilities17,305,000
Long-term Liabilities14,635,000
Total Stockholder Equity16,200,000
Total Current Liabilities
Short-term Debt 12,169,000
Short Long Term Debt 11,918,000
Accounts payable 1,226,000
Other Current Liabilities 3,000
Total Current Liabilities  (as reported)17,305,000
Total Current Liabilities  (calculated)25,316,000
+/- 8,011,000
Long-term Liabilities
Long term Debt 11,562,000
Capital Lease Obligations 1,029,000
Long-term Liabilities Other 7,000
Long-term Liabilities  (as reported)14,635,000
Long-term Liabilities  (calculated)12,598,000
+/- 2,037,000
Total Stockholder Equity
Common Stock228,000
Retained Earnings 16,324,000
Other Stockholders Equity -352,000
Total Stockholder Equity (as reported)16,200,000
Total Stockholder Equity (calculated)16,200,000
+/-0
Other
Capital Stock228,000
Cash and Short Term Investments 889,000
Common Stock Shares Outstanding 224,700
Current Deferred Revenue3,907,000
Liabilities and Stockholders Equity 48,140,000
Net Debt 23,620,000
Net Invested Capital 39,680,000
Net Working Capital -6,914,000
Property Plant and Equipment Gross 6,319,000
Short Long Term Debt Total 24,509,000



Balance Sheet

Currency in DKK. All numbers in thousands.

 Trend2024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-31
> Total Assets 
0
0
0
7,963,000
7,545,000
7,620,000
7,912,000
7,771,000
8,116,000
8,228,000
8,493,000
9,218,000
8,916,000
9,300,000
9,980,000
10,176,000
9,773,000
10,066,000
8,637,000
9,364,000
8,403,000
9,278,000
9,121,000
10,379,000
9,663,000
10,620,000
9,945,000
10,817,000
10,810,000
10,602,000
11,280,000
11,007,000
12,883,000
12,511,000
12,247,000
12,050,000
12,193,000
12,751,000
12,667,000
11,769,000
12,113,000
12,292,000
12,551,000
12,732,000
13,223,000
13,528,000
13,315,000
13,499,000
14,926,000
15,249,000
15,458,000
15,841,000
16,188,000
35,170,000
34,956,000
35,221,000
35,302,000
35,087,000
35,087,000
48,159,000
48,591,000
48,140,000
48,140,00048,591,00048,159,00035,087,00035,087,00035,302,00035,221,00034,956,00035,170,00016,188,00015,841,00015,458,00015,249,00014,926,00013,499,00013,315,00013,528,00013,223,00012,732,00012,551,00012,292,00012,113,00011,769,00012,667,00012,751,00012,193,00012,050,00012,247,00012,511,00012,883,00011,007,00011,280,00010,602,00010,810,00010,817,0009,945,00010,620,0009,663,00010,379,0009,121,0009,278,0008,403,0009,364,0008,637,00010,066,0009,773,00010,176,0009,980,0009,300,0008,916,0009,218,0008,493,0008,228,0008,116,0007,771,0007,912,0007,620,0007,545,0007,963,000000
   > Total Current Assets 
0
0
0
3,369,000
2,997,000
3,007,000
3,188,000
3,353,000
3,491,000
3,775,000
4,145,000
4,965,000
4,664,000
5,128,000
5,720,000
5,969,000
5,654,000
5,975,000
4,551,000
5,366,000
4,426,000
5,095,000
4,972,000
6,047,000
5,251,000
5,884,000
5,338,000
5,765,000
5,733,000
6,009,000
6,646,000
6,164,000
6,915,000
6,608,000
6,518,000
6,194,000
6,322,000
6,641,000
6,494,000
5,590,000
5,929,000
6,097,000
6,415,000
6,359,000
6,361,000
6,709,000
6,490,000
6,489,000
6,640,000
6,707,000
6,827,000
6,994,000
7,284,000
8,169,000
8,772,000
9,279,000
9,323,000
9,673,000
9,673,000
9,937,000
10,069,000
10,391,000
10,391,00010,069,0009,937,0009,673,0009,673,0009,323,0009,279,0008,772,0008,169,0007,284,0006,994,0006,827,0006,707,0006,640,0006,489,0006,490,0006,709,0006,361,0006,359,0006,415,0006,097,0005,929,0005,590,0006,494,0006,641,0006,322,0006,194,0006,518,0006,608,0006,915,0006,164,0006,646,0006,009,0005,733,0005,765,0005,338,0005,884,0005,251,0006,047,0004,972,0005,095,0004,426,0005,366,0004,551,0005,975,0005,654,0005,969,0005,720,0005,128,0004,664,0004,965,0004,145,0003,775,0003,491,0003,353,0003,188,0003,007,0002,997,0003,369,000000
       Cash And Cash Equivalents 
0
0
0
629,000
278,000
237,000
335,000
475,000
350,000
381,000
454,000
1,318,000
848,000
1,496,000
1,914,000
1,973,000
988,000
1,417,000
617,000
1,504,000
462,000
454,000
404,000
971,000
428,000
656,000
644,000
881,000
412,000
402,000
424,000
546,000
545,000
442,000
314,000
314,000
505,000
608,000
450,000
297,000
432,000
312,000
444,000
356,000
516,000
498,000
411,000
323,000
435,000
418,000
447,000
448,000
642,000
517,000
414,000
671,000
628,000
855,000
855,000
911,000
916,000
889,000
889,000916,000911,000855,000855,000628,000671,000414,000517,000642,000448,000447,000418,000435,000323,000411,000498,000516,000356,000444,000312,000432,000297,000450,000608,000505,000314,000314,000442,000545,000546,000424,000402,000412,000881,000644,000656,000428,000971,000404,000454,000462,0001,504,000617,0001,417,000988,0001,973,0001,914,0001,496,000848,0001,318,000454,000381,000350,000475,000335,000237,000278,000629,000000
       Short-term Investments 
0
0
0
1,000
1,000
1,000
1,000
1,000
1,000
180,000
471,000
568,000
659,000
456,000
608,000
645,000
1,337,000
1,149,000
335,000
367,000
475,000
632,000
401,000
619,000
200,000
216,000
210,000
519,000
201,000
200,000
200,000
489,000
379,000
334,000
313,000
315,000
316,000
311,000
311,000
310,000
305,000
308,000
311,000
313,000
304,000
302,000
262,000
262,000
257,000
257,000
228,000
226,000
222,000
220,000
219,000
210,000
16,000
16,000
0
0
0
0
000016,00016,000210,000219,000220,000222,000226,000228,000257,000257,000262,000262,000302,000304,000313,000311,000308,000305,000310,000311,000311,000316,000315,000313,000334,000379,000489,000200,000200,000201,000519,000210,000216,000200,000619,000401,000632,000475,000367,000335,0001,149,0001,337,000645,000608,000456,000659,000568,000471,000180,0001,0001,0001,0001,0001,0001,000000
       Net Receivables 
0
0
0
0
0
0
0
0
1,970,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,703,000
2,713,000
2,918,000
3,190,000
0
0
0
0
0
0
0
0
0
0
0
3,113,000
3,227,000
3,153,000
2,982,000
3,269,000
2,997,000
2,934,000
2,916,000
3,108,000
3,142,000
3,212,000
3,215,000
3,648,000
3,837,000
3,940,000
3,953,000
3,988,000
4,072,000
4,315,000
4,392,000
4,641,000
4,641,0004,392,0004,315,0004,072,0003,988,0003,953,0003,940,0003,837,0003,648,0003,215,0003,212,0003,142,0003,108,0002,916,0002,934,0002,997,0003,269,0002,982,0003,153,0003,227,0003,113,000000000000003,190,0002,918,0002,713,0002,703,000000000000000000001,970,00000000000
       Other Current Assets 
0
0
0
1,753,000
1,803,000
1,788,000
1,890,000
1,918,000
186,000
2,182,000
2,220,000
2,133,000
2,200,000
2,231,000
2,236,000
2,343,000
2,305,000
2,349,000
2,512,000
2,426,000
2,407,000
2,846,000
2,949,000
3,135,000
3,239,000
3,545,000
3,000,000
2,892,000
3,615,000
3,952,000
4,520,000
3,611,000
4,365,000
4,090,000
4,149,000
3,873,000
3,815,000
4,043,000
4,054,000
3,258,000
3,374,000
3,608,000
3,746,000
3,757,000
3,624,000
3,994,000
3,701,000
3,677,000
3,717,000
3,743,000
3,774,000
3,892,000
3,923,000
4,562,000
4,952,000
5,001,000
1,048,000
1,179,000
1,189,000
1,189,000
1,242,000
1,299,000
1,299,0001,242,0001,189,0001,189,0001,179,0001,048,0005,001,0004,952,0004,562,0003,923,0003,892,0003,774,0003,743,0003,717,0003,677,0003,701,0003,994,0003,624,0003,757,0003,746,0003,608,0003,374,0003,258,0004,054,0004,043,0003,815,0003,873,0004,149,0004,090,0004,365,0003,611,0004,520,0003,952,0003,615,0002,892,0003,000,0003,545,0003,239,0003,135,0002,949,0002,846,0002,407,0002,426,0002,512,0002,349,0002,305,0002,343,0002,236,0002,231,0002,200,0002,133,0002,220,0002,182,000186,0001,918,0001,890,0001,788,0001,803,0001,753,000000
   > Long-term Assets 
0
0
0
4,594,000
4,548,000
4,613,000
4,724,000
4,418,000
4,625,000
4,453,000
4,348,000
4,253,000
4,252,000
4,172,000
4,260,000
4,207,000
4,119,000
4,091,000
4,086,000
3,998,000
3,977,000
4,183,000
4,149,000
4,332,000
4,412,000
4,736,000
4,607,000
5,052,000
5,077,000
4,593,000
4,634,000
4,843,000
5,968,000
5,903,000
5,729,000
5,856,000
5,871,000
6,110,000
6,173,000
6,179,000
6,184,000
6,195,000
6,136,000
6,373,000
6,862,000
6,819,000
6,825,000
7,010,000
8,286,000
8,542,000
8,631,000
8,847,000
8,904,000
27,001,000
26,184,000
25,942,000
25,979,000
25,414,000
25,414,000
38,222,000
38,522,000
37,749,000
37,749,00038,522,00038,222,00025,414,00025,414,00025,979,00025,942,00026,184,00027,001,0008,904,0008,847,0008,631,0008,542,0008,286,0007,010,0006,825,0006,819,0006,862,0006,373,0006,136,0006,195,0006,184,0006,179,0006,173,0006,110,0005,871,0005,856,0005,729,0005,903,0005,968,0004,843,0004,634,0004,593,0005,077,0005,052,0004,607,0004,736,0004,412,0004,332,0004,149,0004,183,0003,977,0003,998,0004,086,0004,091,0004,119,0004,207,0004,260,0004,172,0004,252,0004,253,0004,348,0004,453,0004,625,0004,418,0004,724,0004,613,0004,548,0004,594,000000
       Property Plant Equipment 
0
0
0
2,635,000
2,596,000
2,601,000
2,596,000
5,827,000
2,435,000
2,392,000
2,349,000
2,266,000
2,094,000
2,240,000
2,092,000
2,286,000
2,257,000
2,218,000
2,267,000
2,286,000
2,317,000
2,309,000
2,368,000
2,462,000
2,516,000
2,712,000
2,669,000
2,705,000
2,727,000
2,717,000
2,762,000
2,925,000
2,919,000
2,928,000
2,937,000
3,072,000
3,134,000
3,125,000
3,151,000
3,169,000
3,175,000
3,179,000
3,146,000
3,249,000
3,786,000
3,760,000
3,798,000
3,926,000
4,045,000
4,168,000
4,232,000
4,386,000
4,421,000
4,884,000
5,151,000
5,396,000
5,617,000
5,793,000
5,793,000
5,979,000
6,073,000
6,319,000
6,319,0006,073,0005,979,0005,793,0005,793,0005,617,0005,396,0005,151,0004,884,0004,421,0004,386,0004,232,0004,168,0004,045,0003,926,0003,798,0003,760,0003,786,0003,249,0003,146,0003,179,0003,175,0003,169,0003,151,0003,125,0003,134,0003,072,0002,937,0002,928,0002,919,0002,925,0002,762,0002,717,0002,727,0002,705,0002,669,0002,712,0002,516,0002,462,0002,368,0002,309,0002,317,0002,286,0002,267,0002,218,0002,257,0002,286,0002,092,0002,240,0002,094,0002,266,0002,349,0002,392,0002,435,0005,827,0002,596,0002,601,0002,596,0002,635,000000
       Goodwill 
0
0
0
629,000
639,000
674,000
732,000
670,000
785,000
746,000
736,000
737,000
764,000
743,000
783,000
0
750,000
768,000
757,000
735,000
723,000
726,000
730,000
772,000
799,000
877,000
847,000
842,000
862,000
834,000
847,000
844,000
1,800,000
1,772,000
1,665,000
1,724,000
0
0
0
1,984,000
0
0
0
2,030,000
0
0
0
1,976,000
0
0
0
2,028,000
0
10,130,000
11,808,000
11,808,000
-199,000
-747,000
0
19,974,000
0
0
0019,974,0000-747,000-199,00011,808,00011,808,00010,130,00002,028,0000001,976,0000002,030,0000001,984,0000001,724,0001,665,0001,772,0001,800,000844,000847,000834,000862,000842,000847,000877,000799,000772,000730,000726,000723,000735,000757,000768,000750,0000783,000743,000764,000737,000736,000746,000785,000670,000732,000674,000639,000629,000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,000
11,000
11,000
11,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000011,00011,00011,00013,00000000000000000000000000000
       Intangible Assets 
0
0
0
1,179,000
1,162,000
1,184,000
1,220,000
123,000
1,201,000
1,114,000
1,064,000
1,065,000
1,193,000
989,000
1,179,000
0
883,000
867,000
827,000
781,000
742,000
713,000
690,000
709,000
705,000
740,000
697,000
669,000
652,000
604,000
583,000
553,000
732,000
686,000
619,000
571,000
0
0
0
534,000
0
0
0
472,000
0
0
0
388,000
3,524,000
3,614,000
3,634,000
1,623,000
3,677,000
11,069,000
8,469,000
8,469,000
19,802,000
19,603,000
18,856,000
11,281,000
31,440,000
30,403,000
30,403,00031,440,00011,281,00018,856,00019,603,00019,802,0008,469,0008,469,00011,069,0003,677,0001,623,0003,634,0003,614,0003,524,000388,000000472,000000534,000000571,000619,000686,000732,000553,000583,000604,000652,000669,000697,000740,000705,000709,000690,000713,000742,000781,000827,000867,000883,00001,179,000989,0001,193,0001,065,0001,064,0001,114,0001,201,000123,0001,220,0001,184,0001,162,0001,179,000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
669,000
669,000
711,000
709,000
743,000
739,000
0
0
1,891,000
693,000
0
0
0
0
0
00000693,0001,891,00000739,000743,000709,000711,000669,000669,00000000000000000000000000000000000000000000000000
> Total Liabilities 
0
0
0
5,113,000
4,666,000
4,540,000
4,790,000
4,319,000
4,594,000
4,454,000
4,506,000
4,740,000
4,476,000
4,332,000
4,582,000
4,134,000
3,852,000
3,716,000
2,482,000
2,595,000
2,313,000
3,431,000
3,698,000
4,096,000
4,268,000
4,147,000
4,152,000
6,111,000
6,784,000
5,679,000
6,781,000
5,939,000
8,669,000
7,447,000
7,289,000
6,098,000
7,482,000
7,375,000
7,465,000
5,351,000
6,921,000
6,119,000
6,612,000
5,819,000
7,772,000
6,942,000
6,953,000
6,093,000
9,156,000
8,313,000
8,531,000
7,673,000
9,769,000
27,897,000
26,664,000
29,316,000
28,268,000
28,597,000
28,597,000
30,860,000
33,466,000
31,940,000
31,940,00033,466,00030,860,00028,597,00028,597,00028,268,00029,316,00026,664,00027,897,0009,769,0007,673,0008,531,0008,313,0009,156,0006,093,0006,953,0006,942,0007,772,0005,819,0006,612,0006,119,0006,921,0005,351,0007,465,0007,375,0007,482,0006,098,0007,289,0007,447,0008,669,0005,939,0006,781,0005,679,0006,784,0006,111,0004,152,0004,147,0004,268,0004,096,0003,698,0003,431,0002,313,0002,595,0002,482,0003,716,0003,852,0004,134,0004,582,0004,332,0004,476,0004,740,0004,506,0004,454,0004,594,0004,319,0004,790,0004,540,0004,666,0005,113,000000
   > Total Current Liabilities 
0
0
0
1,987,000
1,804,000
1,898,000
2,239,000
2,058,000
1,801,000
1,670,000
1,714,000
2,087,000
1,904,000
1,751,000
3,415,000
3,708,000
3,406,000
3,263,000
2,061,000
2,266,000
1,980,000
2,041,000
2,935,000
3,529,000
3,815,000
3,814,000
3,845,000
4,578,000
5,546,000
4,781,000
6,317,000
5,309,000
8,220,000
6,982,000
6,836,000
5,425,000
6,826,000
6,701,000
6,800,000
4,708,000
6,281,000
5,453,000
5,955,000
4,942,000
6,648,000
5,894,000
5,923,000
4,979,000
7,782,000
6,822,000
7,116,000
6,314,000
8,477,000
24,811,000
7,336,000
10,482,000
9,433,000
9,838,000
9,838,000
16,311,000
18,918,000
17,305,000
17,305,00018,918,00016,311,0009,838,0009,838,0009,433,00010,482,0007,336,00024,811,0008,477,0006,314,0007,116,0006,822,0007,782,0004,979,0005,923,0005,894,0006,648,0004,942,0005,955,0005,453,0006,281,0004,708,0006,800,0006,701,0006,826,0005,425,0006,836,0006,982,0008,220,0005,309,0006,317,0004,781,0005,546,0004,578,0003,845,0003,814,0003,815,0003,529,0002,935,0002,041,0001,980,0002,266,0002,061,0003,263,0003,406,0003,708,0003,415,0001,751,0001,904,0002,087,0001,714,0001,670,0001,801,0002,058,0002,239,0001,898,0001,804,0001,987,000000
       Short-term Debt 
0
0
0
233,000
264,000
335,000
345,000
172,000
207,000
174,000
113,000
98,000
156,000
456,000
1,343,000
1,296,000
1,335,000
1,311,000
146,000
111,000
129,000
130,000
154,000
92,000
367,000
467,000
779,000
100,000
391,000
25,000
923,000
222,000
2,880,000
2,662,000
2,547,000
1,358,000
2,895,000
3,183,000
2,975,000
1,270,000
3,045,000
2,592,000
2,848,000
1,074,000
3,156,000
2,767,000
2,671,000
1,317,000
4,194,000
3,670,000
3,848,000
2,337,000
4,606,000
20,601,000
1,853,000
5,168,000
4,606,000
5,052,000
5,052,000
7,345,000
9,421,000
12,169,000
12,169,0009,421,0007,345,0005,052,0005,052,0004,606,0005,168,0001,853,00020,601,0004,606,0002,337,0003,848,0003,670,0004,194,0001,317,0002,671,0002,767,0003,156,0001,074,0002,848,0002,592,0003,045,0001,270,0002,975,0003,183,0002,895,0001,358,0002,547,0002,662,0002,880,000222,000923,00025,000391,000100,000779,000467,000367,00092,000154,000130,000129,000111,000146,0001,311,0001,335,0001,296,0001,343,000456,000156,00098,000113,000174,000207,000172,000345,000335,000264,000233,000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
779,000
100,000
391,000
25,000
0
0
0
0
0
0
0
0
0
0
0
2,584,000
2,840,000
1,066,000
2,989,000
2,616,000
2,515,000
1,111,000
4,021,000
3,501,000
3,683,000
2,160,000
4,435,000
20,392,000
3,514,000
1,644,000
4,965,000
4,392,000
4,834,000
7,115,000
9,192,000
11,918,000
11,918,0009,192,0007,115,0004,834,0004,392,0004,965,0001,644,0003,514,00020,392,0004,435,0002,160,0003,683,0003,501,0004,021,0001,111,0002,515,0002,616,0002,989,0001,066,0002,840,0002,584,0000000000000025,000391,000100,000779,00000000000000000000000000000
       Accounts payable 
0
0
0
428,000
366,000
344,000
414,000
455,000
1,378,000
428,000
368,000
420,000
399,000
379,000
368,000
478,000
352,000
419,000
433,000
418,000
367,000
430,000
454,000
566,000
396,000
503,000
448,000
591,000
441,000
441,000
525,000
697,000
512,000
566,000
527,000
675,000
550,000
615,000
659,000
751,000
636,000
664,000
673,000
859,000
679,000
664,000
623,000
814,000
563,000
572,000
531,000
1,036,000
597,000
755,000
1,242,000
964,000
1,136,000
1,070,000
1,070,000
1,294,000
1,162,000
1,226,000
1,226,0001,162,0001,294,0001,070,0001,070,0001,136,000964,0001,242,000755,000597,0001,036,000531,000572,000563,000814,000623,000664,000679,000859,000673,000664,000636,000751,000659,000615,000550,000675,000527,000566,000512,000697,000525,000441,000441,000591,000448,000503,000396,000566,000454,000430,000367,000418,000433,000419,000352,000478,000368,000379,000399,000420,000368,000428,0001,378,000455,000414,000344,000366,000428,000000
       Other Current Liabilities 
0
0
0
1,326,000
1,174,000
1,219,000
1,480,000
1,431,000
216,000
1,068,000
1,233,000
1,569,000
1,349,000
1,372,000
1,704,000
1,934,000
1,719,000
1,533,000
1,482,000
1,737,000
1,484,000
1,481,000
2,327,000
2,871,000
3,052,000
2,844,000
2,618,000
3,887,000
4,714,000
4,315,000
4,869,000
15,000
11,000
8,000
4,000
11,000
9,000
6,000
3,000
11,000
9,000
6,000
4,000
11,000
9,000
5,000
3,000
9,000
7,000
4,000
2,000
8,000
6,000
3,455,000
4,241,000
4,350,000
3,691,000
1,000
1,000
1,000
8,335,000
3,000
3,0008,335,0001,0001,0001,0003,691,0004,350,0004,241,0003,455,0006,0008,0002,0004,0007,0009,0003,0005,0009,00011,0004,0006,0009,00011,0003,0006,0009,00011,0004,0008,00011,00015,0004,869,0004,315,0004,714,0003,887,0002,618,0002,844,0003,052,0002,871,0002,327,0001,481,0001,484,0001,737,0001,482,0001,533,0001,719,0001,934,0001,704,0001,372,0001,349,0001,569,0001,233,0001,068,000216,0001,431,0001,480,0001,219,0001,174,0001,326,000000
   > Long-term Liabilities 
0
0
0
3,126,000
2,862,000
2,642,000
2,551,000
2,261,000
2,793,000
2,784,000
2,792,000
2,653,000
2,572,000
2,581,000
1,167,000
426,000
446,000
453,000
421,000
329,000
333,000
1,390,000
763,000
567,000
453,000
333,000
307,000
1,533,000
1,238,000
898,000
464,000
630,000
449,000
465,000
453,000
673,000
656,000
674,000
665,000
643,000
640,000
666,000
657,000
877,000
1,124,000
1,048,000
1,030,000
1,114,000
1,374,000
1,491,000
1,415,000
1,359,000
1,292,000
3,086,000
19,328,000
18,834,000
18,835,000
18,759,000
18,759,000
14,549,000
14,548,000
14,635,000
14,635,00014,548,00014,549,00018,759,00018,759,00018,835,00018,834,00019,328,0003,086,0001,292,0001,359,0001,415,0001,491,0001,374,0001,114,0001,030,0001,048,0001,124,000877,000657,000666,000640,000643,000665,000674,000656,000673,000453,000465,000449,000630,000464,000898,0001,238,0001,533,000307,000333,000453,000567,000763,0001,390,000333,000329,000421,000453,000446,000426,0001,167,0002,581,0002,572,0002,653,0002,792,0002,784,0002,793,0002,261,0002,551,0002,642,0002,862,0003,126,000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
471,000
455,000
433,000
449,000
430,000
0
0
0
0
0
0
0
0
0
000000000430,000449,000433,000455,000471,000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,473,000
1,809,000
0
0
0
0
0
000001,809,0002,473,0000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
2,850,000
2,879,000
3,080,000
3,122,000
3,452,000
3,522,000
3,774,000
3,987,000
4,478,000
4,440,000
4,968,000
5,398,000
6,042,000
5,921,000
6,350,000
6,155,000
6,769,000
6,090,000
5,847,000
5,423,000
6,283,000
5,395,000
6,473,000
5,793,000
4,706,000
4,026,000
4,923,000
4,499,000
5,068,000
4,214,000
5,064,000
4,958,000
5,952,000
4,711,000
5,376,000
5,202,000
6,418,000
5,192,000
6,173,000
5,939,000
6,913,000
5,451,000
6,586,000
6,362,000
7,406,000
5,770,000
6,936,000
6,927,000
8,168,000
6,419,000
7,273,000
8,292,000
5,905,000
7,034,000
6,490,000
6,490,000
17,299,000
15,125,000
16,200,000
16,200,00015,125,00017,299,0006,490,0006,490,0007,034,0005,905,0008,292,0007,273,0006,419,0008,168,0006,927,0006,936,0005,770,0007,406,0006,362,0006,586,0005,451,0006,913,0005,939,0006,173,0005,192,0006,418,0005,202,0005,376,0004,711,0005,952,0004,958,0005,064,0004,214,0005,068,0004,499,0004,923,0004,026,0004,706,0005,793,0006,473,0005,395,0006,283,0005,423,0005,847,0006,090,0006,769,0006,155,0006,350,0005,921,0006,042,0005,398,0004,968,0004,440,0004,478,0003,987,0003,774,0003,522,0003,452,0003,122,0003,080,0002,879,0002,850,000000
   Common Stock
0
0
0
225,000
225,000
225,000
225,000
225,000
225,000
225,000
225,000
225,000
225,000
225,000
225,000
225,000
225,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
228,000
228,000
228,000
228,000228,000228,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000220,000220,000220,000220,000220,000220,000220,000220,000220,000220,000220,000220,000225,000225,000225,000225,000225,000225,000225,000225,000225,000225,000225,000225,000225,000225,000000
   Retained Earnings Total Equity00000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income -1,477,000-1,038,000-1,156,000-1,603,000-816,000-762,000-495,000-370,000000000-5,736,000000-5,463,000000-5,191,000000-4,804,000000-4,672,000000-4,341,000000-3,993,000000-3,856,000000-3,703,000000-3,436,0000000000-3,075,000000
   Capital Surplus 00000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
3,326,000
-44,000
-60,000
-128,000
-21,000
-44,000
34,000
40,000
3,404,000
-99,000
-63,000
-72,000
3,663,000
34,000
660,000
77,000
5,275,000
-43,000
705,000
-183,000
5,351,000
-205,000
815,000
-200,000
5,971,000
-5,000
959,000
-78,000
6,540,000
-84,000
886,000
-7,000
7,001,000
-45,000
950,000
-167,000
7,330,000
-135,000
897,000
-134,000
7,784,000
-246,000
771,000
-278,000
8,186,000
-322,000
640,000
-400,000
2,546,000
-465,000
875,000
2,690,000
-762,000
246,000
-1,603,000
-1,603,000
2,439,000
-1,038,000
-352,000
-352,000-1,038,0002,439,000-1,603,000-1,603,000246,000-762,0002,690,000875,000-465,0002,546,000-400,000640,000-322,0008,186,000-278,000771,000-246,0007,784,000-134,000897,000-135,0007,330,000-167,000950,000-45,0007,001,000-7,000886,000-84,0006,540,000-78,000959,000-5,0005,971,000-200,000815,000-205,0005,351,000-183,000705,000-43,0005,275,00077,000660,00034,0003,663,000-72,000-63,000-99,0003,404,00040,00034,000-44,000-21,000-128,000-60,000-44,0003,326,000000



Balance Sheet

Currency in DKK. All numbers in thousands.




Cash Flow

Currency in DKK. All numbers in thousands.